酒精使用障碍中痛敏肽阿片肽受体的PET成像:[11C]NOP-1A第二队列研究
本研究用[11C]NOP-1A PET测量近期戒酒的酒精使用障碍(AUD)患者与健康对照的痛敏肽阿片肽受体(NOP)分布容积(VT)。AUD与对照组VT无差异,但近期大量饮酒者VT显著更低,且VT与饮酒天数、每日饮酒量负相关;复发者VT显著低于戒酒者。较低NOP VT预测12周随访期内复发。
要点
- AUD患者与健康对照的[11C]NOP-1A VT无显著差异
- 近期大量饮酒的AUD患者NOP VT显著低于无近期大量饮酒者
- 较低NOP VT预测12周随访期内复发
核心结论
- 在寻求治疗的AUD患者中,较低NOP VT预测12周随访期内复发。
研究设计与样本
- 采用[11C]NOP-1A PET测量近期戒酒的AUD患者与健康对照(每组n=27)的VT,基于动脉输入函数动力学分析。
- 用头发乙基葡萄糖醛酸苷(≥30 pg/mg定义为大量饮酒)量化PET前近期大量饮酒。
- 对22例AUD患者在PET后12周内每周3次尿乙基葡萄糖醛酸苷检测随访复发,并以金钱激励戒酒。
主要发现
- AUD患者与健康对照之间[11C]NOP-1A VT无差异。
- 研究前大量饮酒的AUD患者VT显著低于无近期大量饮酒史者。
- VT与入组前30天内饮酒天数和每次饮酒日饮酒量呈显著负相关。
- 复发(并脱落)的AUD患者VT显著低于戒酒12周者。
临床怎么用
- 对近期大量饮酒的AUD患者,可关注NOP系统作为复发风险标志。
- 结果支持研究作用于NOP的药物以预防AUD复发。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Nociceptin, which binds to the nociceptin opioid peptide receptor (NOP), regulates stress and reward in addiction. In a previous [11C]NOP-1A positron emission tomography (PET) study, we found no differences in NOP in non-treatment-seeking individuals with alcohol use disorder (AUD) relative to healthy control subjects Here, we evaluated NOP in treatment-seeking individuals with AUD to document its relationship with relapse to alcohol. METHODS: [11C]NOP-1A distribution volume (VT) was measured in recently abstinent individuals with AUD and healthy control subjects (n = 27/group) using an arterial input function-based kinetic analysis in brain regions that regulate reward and stress behaviors. Recent heavy drinking before PET was quantified using hair ethyl glucuronide (≥30 pg/mg was defined as heavy drinking). To document relapse, 22 subjects with AUD were followed with urine ethyl glucoronide tests (3/week) for 12 weeks after PET, where they were incentivized with money to abstain. RESULTS: There were no differences in [11C]NOP-1A VT between individuals with AUD and healthy control subjects. Individuals with AUD who drank heavily before the study had significantly lower VT than those with no recent heavy drinking history. Significant negative correlations between VT and the number of drinking days and the number of drinks consumed per drinking day in the 30 days before enrollment were also present. Individuals with AUD who relapsed (and dropped out) had significantly lower VT than those who abstained for 12 weeks. CONCLUSIONS: Lower NOP VT in heavy drinking AUD predicted relapse to alcohol during a 12-week follow-up period. The results of this PET study support the need to investigate medications that act at NOP to prevent relapse in individuals with AUD.
引用
- Tollefson S, Stoughton C, Himes ML, et al. Imaging Nociceptin Opioid Peptide Receptors in Alcohol Use Disorder With [11C]NOP-1A and Positron Emission Tomography: Findings From a Second Cohort. Biol Psychiatry. 2023. PMID: 36906499. doi:10.1016/j.biopsych.2022.12.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。